Literature DB >> 340378

Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level.

G Romeo.   

Abstract

In four of the five autosomal dominant porphyrias four different partial enzymatic defects of the porphyrin biosynthetic pathway have been discovered in the last few years. With the exception of protoporphyria, the residual enzymatic activity in carriers of these defects is approximately equal to 50% of that found in controls. In each case the pattern of excretion of porphyrin and/or porphyrin precursors reflects the stie of the partial metabolic block. There are indications, at least in intermittent acute porphyria, that the degree of penetrance of the disorder varies according to the level of phenotypic expression, being highest for the enzyme deficiency, lower for the excretion of precursors and lowest for the clinical symptoms. It is proposed that environmental factors, and probably also gene interaction, are the cause of the different degrees of penetrance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 340378     DOI: 10.1007/bf00295419

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  45 in total

Review 1.  Comparative aspects of porphyria in man and animals.

Authors:  E Y Levin
Journal:  Ann N Y Acad Sci       Date:  1975-04-15       Impact factor: 5.691

2.  Erythropoietic uroporphyria of Gunther first presenting at 58 years with positive family studies.

Authors:  R W Pain; F W Welch; A J Woodroffe; D A Handley; W H Lockwood
Journal:  Br Med J       Date:  1975-09-13

3.  PRESENT STATUS OF THE EHRLICH ALDEHYDE REACTION FOR URINARY PORPHOBILINOGEN.

Authors:  C J WATSON; L TADDEINI; I BOSSENMAIER
Journal:  JAMA       Date:  1964-11-09       Impact factor: 56.272

4.  Hereditary coproporphyria.

Authors:  A Goldberg; C Rimington; A C Lochhead
Journal:  Lancet       Date:  1967-03-25       Impact factor: 79.321

5.  The acute porphyria attack. 3. Acute porphyria: the precipitating and aggravating factors.

Authors:  L Eales
Journal:  S Afr Med J       Date:  1971-09-25

6.  Hematological and blood chemical observations in neonatal normal and porphyric calves in early life.

Authors:  J J Kaneko; R Mills
Journal:  Cornell Vet       Date:  1970-01

7.  Uroporphyrinogen decarboxylase from mouse spleen.

Authors:  G Romeo; E Y Levin
Journal:  Biochim Biophys Acta       Date:  1971-02-23

8.  Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.

Authors:  L J Strand; U A Meyer; B F Felsher; A G Redeker; H S Marver
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Apocytochrome P-450: reconstitution of functional cytochrome with hemin in vitro.

Authors:  M A Correia; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.

Authors:  S Sassa; G Solish; R D Levere; A Kappas
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  3 in total

1.  Familial and sporadic porphyria cutanea: two different diseases.

Authors:  H de Verneuil; G Aitken; Y Nordmann
Journal:  Hum Genet       Date:  1978-10-31       Impact factor: 4.132

2.  A porphyrin pathway impairment is responsible for the phenotype of a dominant disease lesion mimic mutant of maize.

Authors:  G Hu; N Yalpani; S P Briggs; G S Johal
Journal:  Plant Cell       Date:  1998-07       Impact factor: 11.277

3.  Inherited deficiency of delta-aminolevulinic acid dehydratase.

Authors:  T D Bird; P Hamernyik; J Y Nutter; R F Labbe
Journal:  Am J Hum Genet       Date:  1979-11       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.